1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea

C26H33N9O2 — CID 155515571

IUPAC1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea
SMILESCC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(CCN4CCNCC4)c4ncnc(N)c34)cc2)no1
InChIInChI=1S/C26H33N9O2/c1-26(2,3)20-14-21(33-37-20)32-25(36)31-18-6-4-17(5-7-18)19-15-35(13-12-34-10-8-28-9-11-34)24-22(19)23(27)29-16-30-24/h4-7,14-16,28H,8-13H2,1-3H3,(H2,27,29,30)(H2,31,32,33,36)
InChIKeyQJFMRYSLDNTGSK-UHFFFAOYSA-N
MW503.61 g/mol
LogP3.52
Rot. Bonds6

About 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea

1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea (PubChem CID 155515571) has the molecular formula C26H33N9O2 and a molecular weight of 503.61 g/mol. Its IUPAC name is 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea.

Molecular Properties

Compound Name1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea
PubChem CID155515571
Molecular FormulaC26H33N9O2
Molecular Weight503.61 g/mol
Exact Mass503.28
IUPAC Name1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea
SMILESCC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(CCN4CCNCC4)c4ncnc(N)c34)cc2)no1
InChIInChI=1S/C26H33N9O2/c1-26(2,3)20-14-21(33-37-20)32-25(36)31-18-6-4-17(5-7-18)19-15-35(13-12-34-10-8-28-9-11-34)24-22(19)23(27)29-16-30-24/h4-7,14-16,28H,8-13H2,1-3H3,(H2,27,29,30)(H2,31,32,33,36)
InChIKeyQJFMRYSLDNTGSK-UHFFFAOYSA-N
XLogP3.52
TPSA139.16 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500503.61
LogP ≤ 53.52
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Analyze 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea?
The IUPAC name of 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea (CID 155515571) is 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea.
What is the SMILES notation for 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea?
The canonical SMILES for 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea is CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(CCN4CCNCC4)c4ncnc(N)c34)cc2)no1.
What is the InChIKey of 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea?
The InChIKey is QJFMRYSLDNTGSK-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H33N9O2/c1-26(2,3)20-14-21(33-37-20)32-25(36)31-18-6-4-17(5-7-18)19-15-35(13-12-34-10-8-28-9-11-34)24-22(19)23(27)29-16-30-24/h4-7,14-16,28H,8-13H2,1-3H3,(H2,27,29,30)(H2,31,32,33,36).
What are the key properties of 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea?
1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea has a molecular weight of 503.61 g/mol, XLogP of 3.52, 6 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-[4-amino-7-(2-piperazin-1-ylethyl)pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea is sourced from PubChem (CID 155515571), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).